絞り込み

16646

広告

除染廃棄物の焼却灰 容積減らす新施設完成

福島県内の除染廃棄物を燃やして出る、汚染の程度が高い灰の容積を減らすための新しい施設が、福島第一原発の周辺にある中間貯蔵施設の用地に完成しました。

  1. 新型コロナウイルスに関連した患者の発生に...
  2. コウノトリ5年連続産卵か (デイリースポ...
  3. 音楽教室での著作権料めぐる裁判 あす判決...
  4. 新型ウイルス かかりつけ医が症状の特徴学...

ニュース一覧

「"Dunlop BW "[Author]」の検索結果

128件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Concordance between clinician-rated and patient reported outcome measures of depressive symptoms in treatment resistant depression.

Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypes.

Comparing sensitivity to change using the 6-item versus the 17-item Hamilton depression rating scale in the GUIDED randomized controlled trial.

Somatic symptoms in treatment-naïve Hispanic and non-Hispanic patients with major depression.

Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial.

Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.

Investigation of MORC1 DNA methylation as biomarker of early life stress and depressive symptoms.

Changes in trauma-potentiated startle, skin conductance, and heart rate within prolonged exposure therapy for PTSD in high and low treatment responders.

Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment.

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.

Response to: Goldberg et al. and Severance et al. letters to the editor the clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapies.

The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis.

Recall accuracy for the symptoms of a major depressive episode among clinical trial participants.

Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients.

Moving pharmacoepigenetics tools for depression toward clinical use.

Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.

Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.

Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.

When translational neuroscience fails in the clinic: Dexamethasone prior to virtual reality exposure therapy increases drop-out rates.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
Sort by
※並べ替えは表示に時間がかかります